Impact of expression differences of kallikrein-related peptidases and of uPA and PAI-1 between primary tumor and omentum metastasis in advanced ovarian cancer (Q57940964)

From Wikidata

Jump to navigation Jump to search

No description defined

Language	Label	Description	Also known as
English	Impact of expression differences of kallikrein-related peptidases and of uPA and PAI-1 between primary tumor and omentum metastasis in advanced ovarian cancer	No description defined

Statements

scholarly article

0 references

Impact of expression differences of kallikrein-related peptidases and of uPA and PAI-1 between primary tumor and omentum metastasis in advanced ovarian cancer (English)

0 references

1 reference

based on heuristic

inferred from title

Andreas Scorilas

object named as

A. Scorilas

5

0 references

Eleftherios P. Diamandis

object named as

E. Diamandis

7

0 references

author name string

J. Dorn

1

0 references

N. Harbeck

2

0 references

R. Kates

3

0 references

A. Gkazepis

4

0 references

A. Soosaipillai

6

0 references

M. Kiechle

8

0 references

B. Schmalfeldt

9

0 references

M. Schmitt

10

0 references

publication date

5 October 2010

0 references

Annals of Oncology

0 references

22

0 references

4

0 references

877-883

0 references

Radical surgical procedure improves survival time in patients with recurrent ovarian cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ462

21 January 2018

Delaying the primary surgical effort for advanced ovarian cancer: a systematic review of neoadjuvant chemotherapy and interval cytoreduction

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ462

21 January 2018

Prognostic significance of urokinase (uPA) and its inhibitor PAI-1 for survival in advanced ovarian carcinoma stage FIGO IIIc

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ462

21 January 2018

Primary tumor levels of human tissue kallikreins affect surgical success and survival in ovarian cancer patients

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ462

21 January 2018

Disease processes may be reflected by correlations among tissue kallikrein proteases but not with proteolytic factors uPA and PAI-1 in primary ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ462

21 January 2018

Plasmin/plasminogen system in colorectal cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ462

21 January 2018

Expression of urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 in benign, borderline, malignant primary and metastatic ovarian tumors

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ462

21 January 2018

Characterization of hK4 (prostase), a prostate-specific serine protease: activation of the precursor of prostate specific antigen (pro-PSA) and single-chain urokinase-type plasminogen activator and degradation of prostatic acid phosphatase

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ462

21 January 2018

The emerging roles of human tissue kallikreins in cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ462

21 January 2018

The tissue kallikrein family of serine proteases: functional roles in human disease and potential as clinical biomarkers

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ462

21 January 2018

Regulation of 92-kDa Gelatinase B Activity in the Extracellular Matrix by Tissue Kallikrein

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ462

21 January 2018

Characterization of the enzymatic activity of human kallikrein 6: Autoactivation, substrate specificity, and regulation by inhibitors

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ462

21 January 2018

Substrate specificity of human kallikrein 2 (hK2) as determined by phage display technology

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ462

21 January 2018

Human kallikrein 6 activity is regulated via an autoproteolytic mechanism of activation/inactivation.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ462

21 January 2018

New tumor markers: CA125 and beyond.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ462

21 January 2018

Ovarian cancer biomarkers: current options and future promise

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ462

21 January 2018

A Multiparametric Panel for Ovarian Cancer Diagnosis, Prognosis, and Response to Chemotherapy

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ462

21 January 2018

Identifiers

10.1093/ANNONC/MDQ462

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57940964&oldid=1780529837"